OncoDaily
LightNews LightNews
banner
oncodaily.bsky.social
OncoDaily
@oncodaily.bsky.social
3.4K followers 7.8K following 3K posts
Your daily dose of hope, inspiration, and information in the fight against cancer.
oncodaily.com
Posts Replies Media Videos
oncodaily.bsky.social
SIOG 2025 Presidential Session: Priorities, Progress, and a Vision for the Future of Geriatric Oncology

@siogorg.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SIOG25Years #SIOG25th #SIOG25 #SIOG2025 #GeriatricOncology #GeriOnc
SIOG 2025 Presidential: Geriatric Oncology Priorities
A concise recap of the SIOG 2025 presidential session, highlighting key priorities in geriatric oncology and the future of cancer care for older adults.
oncodaily.com
November 24, 2025 at 8:53 PM
oncodaily.bsky.social
Redefining Over- and Undertreatment in Older Adults at SIOG 2025

@siogorg.bsky.social

oncodaily.com/library/over...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SIOG25Years #SIOG25th #SIOG25 #SIOG2025 #GeriatricOncology #Ghent2025 #GeriOnc
Over- and Undertreatment in Older Adults: SIOG 2025 Insights
Preventing over- and undertreatment in older adults through geriatric assessment and patient-centered decision-making. SIOG 2025
oncodaily.com
November 24, 2025 at 8:53 PM
oncodaily.bsky.social
ADCs in Older Adults: Nursing Strategies and Safety Insights from SIOG 2025

@siogorg.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SIOG25Years #SIOG25th #SIOG25 #SIOG2025 #GeriatricOncology #Ghent2025 #GeriOnc
ADCs in Older Adults: Key Nursing Insights from SIOG 2025
A detailed look at nursing essentials for antibody-drug conjugates (ADCs) in older adults, highlighting safety, toxicity management.
oncodaily.com
November 24, 2025 at 8:52 PM
oncodaily.bsky.social
Jarushka Naidoo Among World’s Most Cited Researchers - Patrick Forde

@patrickforde.bsky.social @drjnaidoo.bsky.social

oncodaily.com/voices/patri...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Patrick Forde: Jarushka Naidoo Among World's Most Cited Researchers - OncoDaily
Patrick Forde: Jarushka Naidoo Among World's Most Cited Researchers / cancer, Jarushka Naidoo, OncoDaily, Oncology, Patrick Forde
oncodaily.com
November 24, 2025 at 8:51 PM
oncodaily.bsky.social
Kimmich and Gnabry Visit Children’s Oncology Ward: FC Bayern Donates €25,000

oncodaily.com/stories/cele...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Kimmich and Gnabry Visit Children’s Oncology Ward: FC Bayern Donates €25,000 - OncoDaily
Kimmich and Gnabry Visit Children’s Oncology Ward: FC Bayern Donates €25,000 / cancer, Children’s Oncology Ward, FC Bayern, Haunersche Children’s Hospital,
oncodaily.com
November 24, 2025 at 8:48 PM
oncodaily.bsky.social
Catching Up with Zainab Shinkafi-Bagudu at WCLS 2025 - Todd Harper

@uiccofficial.bsky.social

oncodaily.com/voices/todd-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLS #WCLS25 #WCLS2025
Todd Harper: Catching Up with Zainab Shinkafi-Bagudu at WCLS 2025 - OncoDaily
Todd Harper: Catching Up with Zainab Shinkafi-Bagudu at WCLS 2025 / cancer, OncoDaily, Oncology, Todd Harper, UICC, Union for International Cancer Control,
oncodaily.com
November 24, 2025 at 8:47 PM
oncodaily.bsky.social
Lung Cancer Europe - Émilie’s Story of an Unexpected Lung Cancer Diagnosis

@lungcancereurope.bsky.social

oncodaily.com/voices/lung-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Émilie's Story of an Unexpected Lung Cancer Diagnosis - Lung Cancer Europe - OncoDaily
Émilie's Story of an Unexpected Lung Cancer Diagnosis - Lung Cancer Europe / cancer, Lung cancer, Lung Cancer Europe, OncoDaily, Oncology
oncodaily.com
November 24, 2025 at 8:46 PM
oncodaily.bsky.social
FDA Grants Fast Track Designation to DPTX3186 for Gastric Cancer

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FDA #GastricCancer
FDA Grants Fast Track Designation to DPTX3186 for Gastric Cancer - OncoDaily
DPTX3186, a first-in-class β-catenin condensate modulator, receives FDA Fast Track designation for metastatic gastric cancer, targeting Wnt/β-catenin signaling.
oncodaily.com
November 24, 2025 at 8:45 PM
oncodaily.bsky.social
Insights From SIOG 2025: Managing Toxicities and Surgical Decision-Making in Older Adults With Cancer

@siogorg.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SIOG25Years #SIOG25th #SIOG25 #SIOG2025 #GeriatricOncology #GeriOnc
Insights From SIOG 2025: Managing Toxicities and Surgical Decision-Making in Older Adults With Cancer - OncoDaily
Insights from SIOG 2025 on managing immunotherapy toxicities, surgical risks, nursing care, and wearable monitoring in older adults with cancer.
oncodaily.com
November 24, 2025 at 8:44 PM
oncodaily.bsky.social
Eli Lilly’s Becomes Pharma’s First $1 Trillion Company

@elilillyandcompany.bsky.social

oncodaily.com/industry/eli...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EliLilly
Eli Lilly’s Becomes Pharma's First $1 Trillion Company - OncoDaily
Eli Lilly’s Becomes Pharma's First $1 Trillion Company / Eli Lilly, Mounjaro, OncoDaily, Oncology, Pharma, Zepbound
oncodaily.com
November 24, 2025 at 8:43 PM
oncodaily.bsky.social
World Class Cancer Care in Northern Chicagoland - Ruben Mesa

@rubenmesamd.bsky.social

oncodaily.com/voices/ruben...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Ruben Mesa: World Class Cancer Care in Northern Chicagoland - OncoDaily
Ruben Mesa: World Class Cancer Care in Northern Chicagoland / cancer, OncoDaily, Oncology, Ruben Mesa
oncodaily.com
November 24, 2025 at 12:08 AM
oncodaily.bsky.social
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen: Part 2

@triparnasen.bsky.social @iaslc.bsky.social

oncodaily.com/voices/iaslc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen: Part 2 - OncoDaily
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen: Part 2 / Aaron Tan, cancer, Chaoqiang Deng, Ehab Billatos, Fabrizio
oncodaily.com
November 24, 2025 at 12:07 AM
oncodaily.bsky.social
ASCO - Reminder to Nominate for the Women Who Conquer Cancer Mentorship Award

@ascocancer.bsky.social @conquercancer.bsky.social

oncodaily.com/voices/women...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 24, 2025 at 12:06 AM
oncodaily.bsky.social
One Diagnosis: Five Different Paths - Jill Feldman

@jillfeldman4.bsky.social @oncogenecancer.bsky.social

oncodaily.com/voices/one-d...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Jill Feldman: One Diagnosis - Five Different Paths - OncoDaily
Jill Feldman: One Diagnosis - Five Different Paths / cancer, Jill Feldman, Leah Phillips, OncoDaily, Oncogene Cancer Research, Oncology, Samantha M., Yvonne
oncodaily.com
November 24, 2025 at 12:05 AM
oncodaily.bsky.social
Neoadjuvant Radiotherapy in Soft Tissue Sarcomas

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Radiotherapy #Sarcomas
Neoadjuvant Radiotherapy in Soft Tissue Sarcomas - OncoDaily
Neoadjuvant Radiotherapy in Soft Tissue Sarcomas / cancer, OncoDaily, Oncology, radiation oncology, radiotherapy, soft tissue sarcoma radiotherapy, soft
oncodaily.com
November 24, 2025 at 12:04 AM
oncodaily.bsky.social
Colon Cancer Success Rate: What Patients Need to Know in 2025

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ColonCancer
Colon Cancer Success Rate: What Patients Need to Know in 2025 - OncoDaily
Learn how colon cancer success rates vary by stage, biology, and treatment, and how modern therapies significantly improve survival.
oncodaily.com
November 24, 2025 at 12:03 AM
oncodaily.bsky.social
Oncology This Week: OncoDaily Weekly Nov 17–23

oncodaily.com/not-to-miss/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Oncology This Week: OncoDaily Weekly Nov 17–23 - OncoDaily
Oncology This Week: OncoDaily Weekly Nov 17–23 / 100 Influential Women in Oncology, 100 Influential Women in Oncology in 2025, BIGR, cancer, European Cancer
oncodaily.com
November 24, 2025 at 12:03 AM
oncodaily.bsky.social
Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers - OncoDaily
Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers / cancer, cancer treatment, Headlines,
oncodaily.com
November 24, 2025 at 12:02 AM
oncodaily.bsky.social
Discussing Progress and Future Directions at Brown University - Wafik S. El-Deiry

@weldeiry.bsky.social

oncodaily.com/voices/wafik...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Wafik S. El-Deiry: Discussing Progress and Future Directions at Brown University - OncoDaily
Wafik S. El-Deiry: Discussing Progress and Future Directions at Brown University / Brown University, cancer, Jeff Waldron, OncoDaily, Oncology, Wafik S.
oncodaily.com
November 23, 2025 at 1:41 AM
oncodaily.bsky.social
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen

@triparnasen.bsky.social @iaslc.bsky.social

oncodaily.com/voices/iaslc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen - OncoDaily
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen / cancer, HT25, IASLC 2025, IASLC 2025 Hot Topic, IASLC HT25, International
oncodaily.com
November 23, 2025 at 1:40 AM
oncodaily.bsky.social
Full Program for the 2026 Translating Evidence into Action Conference – MSK CME

@mskcancercenter.bsky.social

oncodaily.com/voices/msk-c...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Full Program for the 2026 Translating Evidence into Action Conference - MSK CME - OncoDaily
Full Program for the 2026 Translating Evidence into Action Conference - MSK CME / cancer, Conference, Memorial Sloan Kettering Cancer Center, Memorial Sloan
oncodaily.com
November 23, 2025 at 1:39 AM
oncodaily.bsky.social
Geriatric Oncology at SIOG 2025: From Research to Real-World Care

@siogorg.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SIOG25Years #SIOG25th #SIOG25 #SIOG2025 #GeriatricOncology #Ghent2025 #GeriOnc #OncologyCommunity
Geriatric Oncology at SIOG 2025: Turning Evidence Into Care
A deep dive into how SIOG 2025 showcased real-world models transforming geriatric oncology, highlighting global approaches.
oncodaily.com
November 23, 2025 at 1:38 AM
oncodaily.bsky.social
Bezuclastinib Achieves Positive PEAK Phase 3 Results in Advanced GIST: A Potential New Standard for KIT Exon 17/18 Mutant Disease

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Bezuclastinib Achieves Positive PEAK Phase 3 Results in Advanced GIST: A Potential New Standard for KIT Exon 17/18 Mutant Disease - OncoDaily
Bezuclastinib shows positive PEAK Phase 3 results in advanced GIST, demonstrating strong activity against KIT exon 17/18 mutations.
oncodaily.com
November 23, 2025 at 1:38 AM
oncodaily.bsky.social
Perspectives on Complexities in Treatment Selection for Older Adults With Lung Cancer – Insights From SIOG 2025

@siogorg.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SIOG25Years #SIOG25th #SIOG25 #SIOG2025 #Ghent2025 #GeriOnc
Geriatric Lung Cancer Care at SIOG 2025
SIOG 2025 highlights key challenges and advances in geriatric lung cancer care, emphasizing multidisciplinary decisions and geriatric assessment.
oncodaily.com
November 23, 2025 at 1:38 AM
oncodaily.bsky.social
HERIZON-GEA-01 Trial Update: Ziihera (zanidatamab-hrii) Sets New Benchmark in First-Line HER2-Positive GEA

oncodaily.com/trial-update...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
HERIZON-GEA-01 Trial Update: Ziihera (zanidatamab-hrii) Sets New Benchmark in First-Line HER2-Positive GEA - OncoDaily
HERIZON-GEA-01 shows Ziihera improves survival over trastuzumab in first-line HER2-positive GEA, signaling a potential new global standard of care.
oncodaily.com
November 23, 2025 at 1:37 AM